Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-02-11 | New | $19,379,799 | $19,379,799 | Equity Only | 06b | SEC link |
| 2023-10-27 | New | $11,054,030 | $11,054,030 | Debt Only | 06b | SEC link |
| 2021-10-25 | Amended | $27,352,547 | $22,586,851 | Equity and Debt | 06b | SEC link |
| 2021-05-26 | New | $4,765,696 | $4,765,696 | Equity Only | SEC link | |
| 2020-05-22 | New | $7,825,000 | $7,825,000 | Debt Only | 06b | SEC link |
| 2019-06-24 | New | $5,000,000 | $5,000,000 | Equity Only | 06b | SEC link |
| 2018-11-21 | New | $20,026,439 | $20,026,439 | Equity Only | 06b | SEC link |
| 2017-06-29 | Amended | $19,150,000 | $9,575,000 | Equity Only | 06b | SEC link |
| 2016-12-07 | New | $9,575,000 | $9,575,000 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Richard P. Aldrich | Director |
| Sakae Asanuma | Director |
| James C. Blair | Director |
| Scott C. Brun | Director |
| A. Stewart Campbell | Director, Executive |
| Michele Cucullu | Director |
| Eric De La Fortelle | Director |
| Michelle Dipp | Director |
| David H. Donabedian | Director, Executive |
| Nora Frey | Director |
| Sarkis K. Mazmanian | Director |
| Sarah Meibusch | Director |
| Mark Ohori | Director |
| Ronald C. Renaud Jr. | Director |
| Rebecca Senter | Executive |
| Henry C. Wolf | Director |
| Jeffrey E. Young | Executive |